You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AADC

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Trial in Shanghai (VGN-R09b)

Recruiting
  • Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
  • Shanghai, No. 1678, Dongfang Road, Pudong New Area, Shanghai, China
    Shanghai Children's Medical Center Affiliated to Shanghai Jiao T
Mar 9, 2023

Aromatic L-Amino Acid Decarboxylase Deficiency Trial in Angers, Toulouse (Plasmatic 3-O-Methyldopa dosage)

Recruiting
  • Aromatic L-Amino Acid Decarboxylase Deficiency
  • Plasmatic 3-O-Methyldopa dosage
  • Angers, France
  • +1 more
Aug 10, 2022

AADC/TDC in Advanced Parkinson's Disease

Not yet recruiting
  • Parkinson Disease
    • (no location specified)
    Dec 9, 2022

    Idiopathic Parkinson's Disease, Parkinson's Disease, Basal Ganglia Disease Trial in United States (VY-AADC01)

    Completed
    • Idiopathic Parkinson's Disease
    • +8 more
    • San Francisco, California
    • +3 more
    Mar 17, 2022

    Aromatic Amino Acid Decarboxylase Deficiency Trial in Taipei (AAV2-hAADC)

    Active, not recruiting
    • Aromatic Amino Acid Decarboxylase Deficiency
    • Taipei, Taiwan
      National Taiwan University Hospital
    Nov 15, 2021

    Long-term Extension Study for Participants of Prior VY-AADC01

    Enrolling by invitation
    • Parkinson's Disease
      • San Francisco, California
        University of California, San Francisco
      Mar 17, 2022

      AADC Deficiency Trial in San Francisco, Columbus (AAV2-hAADC)

      Recruiting
      • AADC Deficiency
      • San Francisco, California
      • +2 more
      Jan 14, 2022

      Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Trial in Taipei (gene therapy)

      Active, not recruiting
      • Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
      • gene therapy
      • Taipei, Taiwan
        National Taiwan University Hospital
      Aug 4, 2021

      AADC Deficiency Trial in Israel, Taiwan, United States (Eladocagene Exuparvovec)

      Recruiting
      • AADC Deficiency
      • Eladocagene Exuparvovec
      • Palo Alto, California
      • +6 more
      Aug 4, 2022

      Parkinson's Disease Trial in United States (VY-AADC02, Sham (Placebo) Surgery)

      Active, not recruiting
      • Parkinson's Disease
      • VY-AADC02
      • Sham (Placebo) Surgery
      • Irvine, California
      • +19 more
      Mar 17, 2022

      Parkinson's Disease Trial in San Francisco, Pittsburgh (VY-AADC01)

      Completed
      • Parkinson's Disease
      • VY-AADC01
      • San Francisco, California
      • +1 more
      Feb 28, 2020

      Heart Failure Trial in Helsinki (CABG surgery, AADC therapy)

      Completed
      • Heart Failure
      • CABG surgery
      • AADC therapy
      • Helsinki, Finland
        Annu Nummi
      Mar 3, 2020

      Parkinson Disease Trial in Shimotsuke (Cohort1, Cohort2)

      Terminated
      • Parkinson Disease
      • Cohort1
      • Cohort2
      • Shimotsuke, Tochigi, Japan
        Jichi Medical University
      Aug 7, 2019

      Congenital Hyperinsulinism, Insulinoma Trial in Fort Worth (Fluorodopa F 18)

      Recruiting
      • Congenital Hyperinsulinism
      • Insulinoma
      • Fluorodopa F 18
      • Fort Worth, Texas
        Cook Children's Medical Center
      Dec 8, 2022

      Cannabis Use Disorder Trial in Charleston, Pickens (Varenicline, Placebo)

      Recruiting
      • Cannabis Use Disorder
      • Charleston, South Carolina
      • +1 more
      Oct 5, 2021

      Ischemic Heart Disease, Ischemic Cardiomyopathy, Heart Failure, Systolic Trial (procedure, diagnostic test, other)

      Not yet recruiting
      • Ischemic Heart Disease
      • +6 more
      • Epicardial AAMs-patch transplantation
      • +8 more
      • (no location specified)
      Nov 18, 2022

      Autoimmune Polyglandular Syndrome Type I, Autoimmune Keratitis Trial (Detection of autoantibodies)

      Completed
      • Autoimmune Polyglandular Syndrome Type I
      • Autoimmune Keratitis
      • Detection of autoantibodies
      • (no location specified)
      May 2, 2020

      18F-FDOPA PET in Research of Association Between HCV Infection

      Unknown status
      • Hepatitis C
        • Douliu City, Yunlin County, Taiwan
          National Taiwan University Hospital
        Nov 1, 2020

        Opioid Use Disorder (OUD) Trial in United States (SL-BUP, XR-BUP, XR-NTX)

        Recruiting
        • Opioid Use Disorder (OUD)
        • Little Rock, Arkansas
        • +18 more
        Jun 8, 2022

        Parkinson's Disease Trial in Worldwide (Stalevo, levodopa MR)

        Completed
        • Parkinson's Disease
        • Turku, Finland
        • +3 more
        Apr 4, 2018

        Aromatic L-amino Acid Decarboxylase Deficiency

        Completed
        • Aromatic L-amino Acid Decarboxylase Deficiency
          • Taipei, Taiwan
            National Taiwan University Hospital
          Apr 26, 2017

          Parkinson's Disease Trial in San Francisco (AAV-hAADC-2)

          Completed
          • Parkinson's Disease
          • AAV-hAADC-2
          • San Francisco, California
            University of California, San Francisco
          Dec 2, 2013

          Neuroblastoma Trial in Taipei

          Unknown status
          • Neuroblastoma
            • Taipei, Taiwan
              National Taiwan University Children Hospital
            Apr 11, 2014